EarningsQ2 2026 Earnings Report

Arrowhead Pharmaceuticals (ARWR) Q2 2026 Earnings Report

0 Followers

MX:ARWR Q2 2026 EPS Results

Actual EPS-$16.89

Consensus EPS-$19.89

Beat/MissBeat by +$3.00

One Year Ago EPS$49.94

Actual Revenue$1.34B

Expected Revenue$1.34B

Beat/MissMissed by -$1.91M

YoY Revenue Growth-86.41%

QuarterQ2 2026

Date05/07/2026

TimeAfter Close

Conference CallThursday, May 7, 2026

MX:ARWR Upcoming Earnings

Arrowhead Pharmaceuticals's next earnings date is estimated for November 30, 2026, based on past reporting schedules.

MX:ARWR Q2 2026 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 30, 2026	2026 (Q4)	-28.17 / -	-1.998	―
Aug 04, 2026	2026 (Q3)	-23.19 / -24.70	-22.883	-7.94% (-1.82)
May 07, 2026	2026 (Q2)	-19.89 / -16.89	49.944	-133.82% (-66.83)
Feb 05, 2026	2026 (Q1)	0.67 / 4.00	-25.244	115.83% (+29.24)
Nov 25, 2025	2025 (Q4)	-2.03 / -2.00	-24.699	91.91% (+22.70)
Aug 07, 2025	2025 (Q3)	-17.29 / -22.88	-25.063	8.70% (+2.18)
May 12, 2025	2025 (Q2)	-3.40 / 49.94	-18.525	369.61% (+68.47)
Feb 10, 2025	2025 (Q1)	-8.64 / -25.24	-22.52	-12.10% (-2.72)
Nov 26, 2024	2024 (Q4)	-20.34 / -24.70	-18.525	-33.33% (-6.17)
Aug 08, 2024	2024 (Q3)	-9.61 / -25.06	-17.435	-43.75% (-7.63)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed